GANG LIU,MARK W HOLLADAY,MARTIN W ROWBOTTOM,MICHAEL D HOCKER,MICHAEL J HADD,SHIMIN XU
申请号：
BR112014009006
公开号：
BR112014009006A2
申请日:
2012.10.12
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFR&bgr； kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
